Influenza Vaccine Product Family
Influenza Vaccine (Split Virion), lnactivated – Anflu®
Pandemic Influenza Vaccine, lnactivated, Adjuvanted – Panflu®
H1N1 Influenza A Vaccine (Split Virion), lnactivated – Panflu.1®
Influenza Vaccine (Split Virion), lnactivated, Quadrivalent – TetrAnflu®
Anflu®, preservative-free trivalent influenza vaccine, was launched in 2006.
Panflu®, H5N1 flu vaccine, is the first of its kind in China and was approved for national stockpiling in 2008.
Panfu.1®, world's first H1N1 influenza A vaccine, was approved in 2009 and is used for massive inoculation around the world.
TetrAnflu®, quadrivalent influenza vaccine, was launched in 2020:
Provides complete coverage against all four types of influenza viruses and corresponding strains.
Demonstrates a low occurrence of adverse reactions and excellent safety.
Serum protection rates for each type are greater than 90%, which exceeds EU standards.